Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

News

Another $10m fine coming?

Posted 17 February 2021

A company and its principal found guilty of breaching the Therapeutic Goods Act could face fines similar to the $10 million levied in a case from last year.

The TGA has won in the Federal Court against Evolution Supplements Australia and its sole director Cumhur Keskin. They were found to have continued to advertise prescription substances in defiance of a direction from the regulator.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Approvals Action
Pfizer vs Humira
Adds to a growing list of adalimumab biosims
Top of the Hill
How not to reform the PBAC
In the face of deep change, is piecemeal enough?
Special Report
Aust Covid Vaccine Tracker
UPDATE: Distribution of two mRNA vaccines overseas